Glucose metrics and device satisfaction in adults with type 1 diabetes using different treatment modalities: a multicenter, real-world observational study.
Adults
Continuous subcutaneous insulin infusion
Device satisfaction
Hybrid closed loop
Time in range
Treatment
Type 1 diabetes
Journal
Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299
Informations de publication
Date de publication:
10 Oct 2024
10 Oct 2024
Historique:
received:
15
06
2024
accepted:
26
09
2024
medline:
13
10
2024
pubmed:
13
10
2024
entrez:
10
10
2024
Statut:
aheadofprint
Résumé
To evaluate glucose metrics, device satisfaction and diabetes impact in adults with type 1 diabetes using different treatment modalities in a real-life setting in Italy. This was a multicentre, nationwide, cross-sectional study. Candidates were consecutively evaluated for eligibility during their routine medical visit at the diabetes centre. Researchers collected comprehensive demographic, socioeconomic, anamnestic and clinical data, and administered the Diabetes Impact and Device Satisfaction scale. From 2021 to 2022, a total of 428 subjects, 45% males, with a median age of 32 years (IQR 23-47) were recruited in 11 participating centres from all over Italy. No differences in age, physical activity, and diabetes impact were found for the different treatment modalities. HCL/AHCL and SAP groups reported higher device satisfaction vs. MDI + SMBG and MDI + CGM (p < 0.001). Subjects treated with HCL/AHCL exhibited significantly higher TIR and significantly lower time spent in hypoglycemia level 1, time spent in hyperglycemia, CV and GMI compared to MDI + CGM, and significantly higher TIR and significantly lower time spent in hypoglycemia level 2, time spent in hyperglycemia, and CV compared to SAP. Significant reduction in hypoglycemia level 2 was also found with PLGM compared to SAP. High education attainment was associated with optimal metabolic control. Real-life use of advanced technologies for type 1 diabetes is associated with improved glucose metrics and device satisfaction. Education level also contributes to success of treatment.
Identifiants
pubmed: 39387915
doi: 10.1007/s00592-024-02381-3
pii: 10.1007/s00592-024-02381-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Renard E, Ikegami H, Daher Vianna AG, Pozzilli P, Brette S, Bosnyak Z, Lauand F, Peters A, Pilorget V, Jurišić-Eržen D, Kesavadev J, Seufert J, Wilmot EG (2021) The SAGE study: global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM. Diabetes Metab Res Rev 37(7):e3430. https://doi.org/10.1002/dmrr.3430 Epub 2021 Mar 2. PMID: 33369842; PMCID: PMC8518876
doi: 10.1002/dmrr.3430
Pickup JC, Sutton AJ (2008) Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med 25:765–774
doi: 10.1111/j.1464-5491.2008.02486.x
Dicembrini I, Cosentino C, Monami M, Mannucci E, Pala L (2021) Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials. Acta Diabetol 58:401–410
doi: 10.1007/s00592-020-01589-3
Castellana M, Parisi C, Di Molfetta S, Di Gioia L, Natalicchio A, Perrini S, Cignarelli A, Laviola L, Giorgino F (2020) Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis. BMJ Open Diabetes Res Care 8(1):e001092. https://doi.org/10.1136/bmjdrc-2019-001092 PMID: 32487593; PMCID: PMC7265013
doi: 10.1136/bmjdrc-2019-001092
Irace C, Cutruzzolà A, Nuzzi A, Assaloni R, Brunato B, Pitocco D, Tartaglione L, Di Molfetta S, Cignarelli A, Laviola L, Citro G, Lovati E, Gnasso A, Tweden KS, Kaufman FR (2020) Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes. Diabetes Obes Metab 22(7):1056–1061. https://doi.org/10.1111/dom.13993 Epub 2020 Feb 27. PMID: 32037699; PMCID: PMC7317779
doi: 10.1111/dom.13993
Charleer S, Mathieu C, Nobels F, De Block C, Radermecker RP, Hermans MP, Taes Y, Vercammen C, T’Sjoen G, Crenier L, Fieuws S, Keymeulen B, Gillard P (2018) RESCUE Trial Investigators. Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study. J Clin Endocrinol Metab. 103(3):1224–1232. https://doi.org/10.1210/jc.2017-02498 . PMID: 29342264
Ang E, Lee ZX, Moore S, Nana M (2020) Flash glucose monitoring (FGM): a clinical review on glycaemic outcomes and impact on quality of life. J Diabetes Complications 34:107559
doi: 10.1016/j.jdiacomp.2020.107559
Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Perkins BA, Welsh JB, Willi SM, Wood MA, STAR 3 Study Group (2011) Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase. Diabetes Care 34(11):2403–2405. https://doi.org/10.2337/dc11-1248 Epub 2011 Sep 20. PMID: 21933908; PMCID: PMC3198292
doi: 10.2337/dc11-1248
Abraham MB, Nicholas JA, Smith GJ, Fairchild JM, King BR, Ambler GR, Cameron FJ, Davis EA, Jones TW, PLGM Study Group (2018) Reduction in Hypoglycemia with the predictive low-glucose management system: a long-term Randomized Controlled Trial in adolescents with type 1 diabetes. Diabetes Care 41(2):303–310. https://doi.org/10.2337/dc17-1604 Epub 2017 Nov 30. PMID: 29191844
doi: 10.2337/dc17-1604
Biester T, Tauschmann M, Chobot A, Kordonouri O, Danne T, Kapellen T, Dovc K (2022) The automated pancreas: a review of technologies and clinical practice. Diabetes Obes Metab 24(Suppl 1):43–57. https://doi.org/10.1111/dom.14576 Epub 2021 Nov 14. PMID: 34658126
doi: 10.1111/dom.14576
Franceschi R, Mozzillo E, Di Candia F, Maines E, Leonardi L, Girardi M, Fedi L, Rosanio FM, Marcovecchio ML (2023) A systematic review on the impact of commercially available hybrid closed loop systems on psychological outcomes in youths with type 1 diabetes and their parents. Diabet Med 40(9):e15099. https://doi.org/10.1111/dme.15099 Epub 2023 Apr 17. PMID: 37029751
doi: 10.1111/dme.15099
Cherubini V, Fargalli A, Arnaldi C, Bassi M, Bonfanti R, Patrizia Bracciolini G, Cardella F, Dal Bo S, Delvecchio M, Di Candia F, Franceschi R, Maria Galassi S, Gallo F, Graziani V, Iannilli A, Mameli C, Marigliano M, Minuto N, Monti S, Mozzillo E, Pascarella F, Predieri B, Rabbone I, Roppolo R, Schiaffini R, Tiberi V, Tinti D, Toni S, Scaramuzza A, Vestrucci B, Gesuita R (2024) Glucometrics and device satisfaction in children and adolescents with type 1 diabetes using different treatment modalities: a multicenter real-world observational study. Diabetes Res Clin Pract 210:111621. https://doi.org/10.1016/j.diabres.2024.111621 Epub 2024 Mar 16. PMID: 38499182
doi: 10.1016/j.diabres.2024.111621
Manning ML, Singh H, Stoner K, Habif S (2020) The development and psychometric validation of the diabetes impact and device satisfaction scale for individuals with type 1 diabetes. J Diabetes Sci Technol 14(2):309–317
doi: 10.1177/1932296819897976
Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ 3rd, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M (2019) Clinical targets for continuous glucose Monitoring Data Interpretation: recommendations from the International Consensus on Time in Range. Diabetes Care 42(8):1593–1603. https://doi.org/10.2337/dci19-0028 Epub 2019 Jun 8. PMID: 31177185; PMCID: PMC6973648
Beato-Víbora PI, Gallego-Gamero F, Ambrojo-López A (2021) Real-world outcomes with different technology modalities in type 1 diabetes. Nutr Metab Cardiovasc Dis. 31(6):1845–1850. https://doi.org/10.1016/j.numecd.2021.02.028 . Epub 2021 Mar 3. PMID: 33838993
Müller L, Habif S, Leas S, Aronoff-Spencer E (2019) Reducing hypoglycemia in the Real World: a retrospective analysis of predictive low-glucose Suspend Technology in an ambulatory insulin-dependent cohort. Diabetes Technol Ther 21(9):478–484. https://doi.org/10.1089/dia.2019.0190 Epub 2019 Aug 1. PMID: 31329468; PMCID: PMC6708266
doi: 10.1089/dia.2019.0190
Grunberger G, Sherr J, Allende M, Blevins T, Bode B, Handelsman Y, Hellman R, Lajara R, Roberts VL, Rodbard D, Stec C, Unger J (2021) American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus. Endocr Pract. 27(6):505–537. https://doi.org/10.1016/j.eprac.2021.04.008 . PMID: 34116789
Associazione dei Medici Diabetologi (AMD), della Società Italiana di Diabetologia (SID) e della Società Italiana di Endocrinologia e Diabetologia Pediatrica (SIEDP). Linea Guida della Associazione dei Medici Diabetologi (AMD), della Società Italiana di Diabetologia (SID) e della Società Italiana di Endocrinologia e Diabetologia Pediatrica (SIEDP) La terapia del diabete mellito di tipo 1. Accessed on 11 (2024) https://www.iss.it/-/snlg-diabete-mellito-tipo1
Rossi A, Montefusco L, Reseghetti E, Pastore IF, Rossi G, Usuelli V, Loretelli C, Boci D, Ben Nasr M, D’Addio F, Bucciarelli L, Argenti S, Morpurgo P, Lunati ME, Fiorina P (2023) Daytime hypoglycemic episodes during the use of an advanced hybrid closed loop system. Diabetes Res Clin Pract. 206:111011. https://doi.org/10.1016/j.diabres.2023.111011 . Epub 2023 Nov 11. PMID: 37956944
Bruttomesso D, Irace C, Pozzilli P, SAGE study group (2023) A sub-analysis of the SAGE study in Italy indicates good glycemic control in type 1 diabetes. Nutr Metab Cardiovasc Dis 33(3):631–639 Epub 2022 Nov 17. PMID: 36670006
doi: 10.1016/j.numecd.2022.11.008
Diabetes Research in Children Network (DirecNet) Study Group (2005) Youth and parent satisfaction with clinical use of the GlucoWatch G2 biographer in the management of pediatric type 1 diabetes. Diabetes Care 28(8):1929–1935. https://doi.org/10.2337/diacare.28.8.1929 PMID: 16043734; PMCID: PMC1414784
doi: 10.2337/diacare.28.8.1929
Tansey M, Laffel L, Cheng J, Beck R, Coffey J, Huang E, Kollman C, Lawrence J, Lee J, Ruedy K, Tamborlane W, Wysocki T, Xing D, Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2011). Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabet Med. 28(9):1118-22. https://doi.org/10.1111/j.1464-5491.2011.03368.x . PMID: 21692844
Lal RA, Basina M, Maahs DM, Hood K, Buckingham B, Wilson DM (2019) One year clinical experience of the First Commercial Hybrid closed-Loop System. Diabetes Care 42(12):2190–2196. https://doi.org/10.2337/dc19-0855 Epub 2019 Sep 23. PMID: 31548247; PMCID: PMC6868462
doi: 10.2337/dc19-0855
Yuan CY, Kong YW, Amoore T, Brown K, Grosman B, Jenkins A, Jones H, Kurtz N, Lee MH, MacIsaac R, Netzer E, Paldus B, Robinson L, Roy A, Sims CM, Trawley S, Vogrin S, O’Neal DN (2024) Improved Satisfaction While Maintaining Safety and High Time in Range (TIR) With a Medtronic Investigational Enhanced Advanced Hybrid Closed-Loop (e-AHCL) System. Diabetes Care. 47(4):747–755. https://doi.org/10.2337/dc23-2217 . PMID: 38381515
Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, Hovorka R, Kovatchev BP, Messer LH, Parkin CG, Ambler-Osborn L, Amiel SA, Bally L, Beck RW, Biester S, Biester T, Blanchette JE, Bosi E, Boughton CK, Breton MD, Brown SA, Buckingham BA, Cai A, Carlson AL, Castle JR, Choudhary P, Close KL, Cobelli C, Criego AB, Davis E, de Beaufort C, de Bock MI, DeSalvo DJ, DeVries JH, Dovc K, Doyle FJ, Ekhlaspour L, Shvalb NF, Forlenza GP, Gallen G, Garg SK, Gershenoff DC, Gonder-Frederick LA, Haidar A, Hartnell S, Heinemann L, Heller S, Hirsch IB, Hood KK, Isaacs D, Klonoff DC, Kordonouri O, Kowalski A, Laffel L, Lawton J, Lal RA, Leelarathna L, Maahs DM, Murphy HR, Nørgaard K, O’Neal D, Oser S, Oser T, Renard E, Riddell MC, Rodbard D, Russell SJ, Schatz DA, Shah VN, Sherr JL, Simonson GD, Wadwa RP, Ward C, Weinzimer SA, Wilmot EG, Battelino T (2023) Consensus recommendations for the Use of Automated insulin Delivery technologies in clinical practice. Endocr Rev 44(2):254–280. https://doi.org/10.1210/endrev/bnac022 PMID: 36066457; PMCID: PMC9985411
doi: 10.1210/endrev/bnac022
Pitocco D, Laurenzi A, Tomaselli L, Assaloni R, Consoli A, Di Bartolo P, Guardasole V, Lombardo F, Maffeis C, Rossi A, Gesuita R, Di Molfetta S, Rigamonti A, Scaramuzza A, Irace C, Cherubini V, Working group of Diabetes and Technology AMD-SID-SIEDP (2022) Health care organization and use of technological devices in people with diabetes in Italy: results from a survey of the Working Group on Diabetes and Technology. Nutr Metab Cardiovasc Dis 32(10):2392–2398 Epub 2022 Jul 16. PMID: 35970683
doi: 10.1016/j.numecd.2022.07.003
Pauley ME, Berget C, Messer LH, Forlenza GP (2021) Barriers to Uptake of Insulin Technologies and Novel solutions. Med Devices (Auckl) 14:339–354. https://doi.org/10.2147/MDER.S312858 PMID: 34803408; PMCID: PMC8594891
doi: 10.2147/MDER.S312858
Sumnik Z, Szypowska A, Iotova V, Bratina N, Cherubini V, Forsander G, Jali S, Raposo JF, Stipančic G, Vazeou A, Veeze H, Lange K, SWEET study group (2019). Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective. Pediatr Diabetes. 20(4):434–443. https://doi.org/10.1111/pedi.12833 . Epub 2019 Apr 11. PMID: 30773756
Marden S, Thomas PW, Sheppard ZA, Knott J, Lueddeke J, Kerr D (2012) Poor numeracy skills are associated with glycaemic control in Type 1 diabetes. Diabet Med.29(5):662-9. https://doi.org/10.1111/j.1464-5491.2011.03466.x . PMID: 21978203
Kerr D (2010) Poor numeracy: the elephant in the diabetes technology room. J Diabetes Sci Technol 4(6):1284–1287. https://doi.org/10.1177/193229681000400601 PMID: 21129322; PMCID: PMC3005037
doi: 10.1177/193229681000400601
Abraham MB, de Bock M, Paramalingam N, O’Grady MJ, Ly TT, George C, Roy A, Spital G, Karula S, Heels K, Gebert R, Fairchild JM, King BR, Ambler GR, Cameron F, Davis EA, Jones TW (2016) Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System. Diabetes Technol Ther. 18(7):436 – 43. https://doi.org/10.1089/dia.2015.0364 . Epub 2016 May 5. PMID: 27148807
Petrovski G, Campbell J, Pasha M, Day E, Hussain K, Khalifa A, van den Heuvel T (2023) Simplified meal announcement Versus Precise Carbohydrate counting in adolescents with type 1 diabetes using the MiniMed 780G Advanced Hybrid Closed Loop System: a randomized controlled trial comparing glucose control. Diabetes Care 46(3):544–550. https://doi.org/10.2337/dc22-1692 PMID: 36598841; PMCID: PMC10148675
doi: 10.2337/dc22-1692
Cuenca-Garcia M, Jago R, Shield JP, Burren CP (2012) How does physical activity and fitness influence glycaemic control in young people with type 1 diabetes? Diabet Med
Aouadi R, Khalifa R, Aouidet A et al (2011) Aerobic training programs and glycemic control in diabetic children in relation to exercise frequency. J Sports Med Phys Fit 51:393–400
Schweiger B, Klingensmith G, Snell-Bergeon JK (2010) Physical activity in adolescent females with type 1 diabetes. Int J Pediatr 2010:328318
doi: 10.1155/2010/328318
Ramalho AC, de Lourdes Lima M, Nunes F et al (2006) The effect of resistance versus aerobic training on metabolic control in patients with type-1 diabetes mellitus. Diabetes Res Clin Pract 72:271–276
doi: 10.1016/j.diabres.2005.11.011
Aman J, Skinner TC, de Beaufort CE, Swift PG, Aanstoot HJ, Cameron F (2009) Associations between physical activity, sedentary behavior, and glycemic control in a large cohort of adolescents with type 1 diabetes: the Hvidoere Study Group on Childhood Diabetes. Pediatr Diabetes 10:234–239. https://doi.org/10.1111/j.399-5448.2008.00495.x
doi: 10.1111/j.399-5448.2008.00495.x
Colberg SR, Laan R, Dassau E, Kerr D (2015) Physical activity and type 1 diabetes: time for a rewire? J Diabetes Sci Technol 9(3):609–618 doi: 10.1177/1932296814566231. Epub 2015 Jan 6. PMID: 25568144; PMCID: PMC4604550
doi: 10.1177/1932296814566231
Tagougui S, Taleb N, Rabasa-Lhoret R (2019) The benefits and limits of Technological advances in glucose management around physical activity in patients type 1 diabetes. Front Endocrinol (Lausanne) 9:818. https://doi.org/10.3389/fendo.2018.00818 PMID: 30713524; PMCID: PMC6346637
doi: 10.3389/fendo.2018.00818
González-Vidal T, Rivas-Otero D, Agüeria-Cabal P, Ramos-Ruiz G, Delgado E, Menéndez-Torre E (2024) Continuous glucose monitoring alarms in adults with type 1 diabetes: user characteristics and the Impact of Hypoglycemia and hyperglycemia alarm thresholds on Glycemic Control. Diabetes Technol Ther 26(5):313–323 Epub 2024 Mar 8. PMID: 38156962
doi: 10.1089/dia.2023.0460